SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001485003-16-000128
Filing Date
2016-07-07
Accepted
2016-07-07 16:36:43
Documents
3
Effectiveness Date
2016-07-07

Document Format Files

Seq Description Document Type Size
1 8-K ebio_indclearance8-kx15650.htm DEFA14A 39745
2 EXHIBIT 99.1 elevenbio-pressreleaseindc.htm EX-99.1 14967
3 ebiologoa05.jpg GRAPHIC 89522
  Complete submission text file 0001485003-16-000128.txt   178887
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 161756948
SIC: 2834 Pharmaceutical Preparations